| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.058 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.086 | 0.6 |